{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:21:58Z","timestamp":1791922918581,"version":"4.3.4"},"reference-count":17,"publisher":"BMJ","issue":"6419","license":[{"start":{"date-parts":[[1984,3,10]],"date-time":"1984-03-10T00:00:00Z","timestamp":447724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1984,3,10]]},"abstract":"<jats:p>Eighteen patients with a history of urticaria or asthma, or both, induced by aspirin were studied before and after provocation of symptoms with aspirin. The plasma prostaglandin F2 alpha concentration, which was characteristically raised before challenge, fell significantly at the time of adverse reactions. Repeated administration of aspirin up to a dose of 650 mg daily induced tolerance in most of the patients, and several developed bronchodilator responses to aspirin. Although median total IgE concentrations may be raised in patients with aspirin sensitivity, it appears likely that pharmacological rather than immunological mechanisms are chiefly responsible for the phenomena of aspirin sensitivity and desensitisation.<\/jats:p>","DOI":"10.1136\/bmj.288.6419.745","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"745-748","source":"Crossref","is-referenced-by-count":41,"title":["Effect of aspirin in \"aspirin sensitive\" patients."],"prefix":"10.1136","volume":"288","author":[{"given":"S I","family":"Asad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L J","family":"Youlten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A W","family":"Frankland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Lessof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1984,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","article-title":"Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges","volume":"66","author":"Stevenson, D.D.; Simon, R.A.; Mathison, D.A.","year":"1980","unstructured":"Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980;66:82-8.","journal-title":"J Allergy Clin Immunol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2222.1983.tb02622.x","article-title":"Specific desensitization in \"aspirinsensitive\" urticaria; plasma prostaglandin levels and clinical manifestations","volume":"13","author":"Asad, S.I.; Youlten, L.J.F.; Lessof, M.H.","year":"1983","unstructured":"Asad SI, Youlten LJF, Lessof MH. Specific desensitization in \"aspirinsensitive\" urticaria; plasma prostaglandin levels and clinical manifestations. Clin Allergy 1983;13:459-66.","journal-title":"Clin Allergy"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000230534","article-title":"Immunologic effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations","volume":"41","author":"AL, De Weck","year":"1971","unstructured":"De Weck AL. Immunologic effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. Int Arch Allergy Appl Immunol 1971;41:393-418.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1398-9995.1974.tb01668.x","article-title":"IgE mediated and non-IgE mediated allergictype reactions to aspirin","volume":"29","author":"JA, I.Phills; L, Perelmutter","year":"1974","unstructured":"I Phills JA, Perelmutter L. IgE mediated and non-IgE mediated allergictype reactions to aspirin. Acta Allergologica 1974;29:474-90.","journal-title":"Acta Allergologica"},{"key":"ref_5","first-page":"402","article-title":"Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma","volume":"124","author":"Schulman, E.S.; Newball, H.H.; Demers, L.M.; Fitzpatrick, F.A.; NF, Jr, Adkinson","year":"1981","unstructured":"Schulman ES, Newball HH, Demers LM, Fitzpatrick FA, Adkinson NF Jr. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis 1981; 124:402-6.","journal-title":"Am Rev Respir Dis"},{"key":"ref_6","first-page":"13","article-title":"A detailed investigation of circulating IgE levels in a normal population","volume":"1","author":"Nye, L.; Merrett, T.G.; Landon, J.; White, R.J.","year":"1975","unstructured":"Nye L, Merrett TG, Landon J, White RJ. A detailed investigation of circulating IgE levels in a normal population. Clin Allergy 1975;1:13-24.","journal-title":"Clin Allergy"},{"key":"ref_7","first-page":"311","article-title":"Radioimmunoassay of prostaglandin Fa, El and E2 in human plasma. Eur GClin Invest","volume":"5","author":"Dray, F.; Charbonnel, B.; Maclouf, J.","year":"1975","unstructured":"Dray F, Charbonnel B, Maclouf J. Radioimmunoassay of prostaglandin Fa, El and E2 in human plasma. Eur GClin Invest 1975;5:311-8."},{"key":"ref_8","first-page":"1249","article-title":"Aspirin idiosyncracy, asthma and urticaria","volume-title":"principles and practice","author":"Spector, S.L.; Farr, R.S.","year":"1983","unstructured":"Spector SL, Farr RS. Aspirin idiosyncracy, asthma and urticaria. In: Middleton E, Reed CE, Ellis EF, eds. Allergy: principles and practice. 2nd ed. St Louis: CV Mosby, 1983:1249-73.","edition":"2nd ed"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2222.1976.tb01934.x","article-title":"Oral aspirin challenges in asthmatic patients: a study of plasma histamine","volume":"6","author":"Stevenson, D.D.; Arroyave, C.M.; Bhat, K.N.; Tan, E.M.","year":"1976","unstructured":"Stevenson DD, Arroyave CM, Bhat KN, Tan EM. Oral aspirin challenges in asthmatic patients: a study of plasma histamine. Clin Allergy 1976; 6:493-505.","journal-title":"Clin Allergy"},{"key":"ref_10","article-title":"In vitro prostaglandins (PGs) production by monocytes of asthmatics and normal subjects","volume":"10","author":"Ong, K.S.; Del Duca, C.; Weaser, J.L.; Wells, I.D.; Novey, H.S.","year":"1981","unstructured":"Ong KS, Del Duca C, Weaser JL, Wells ID, Novey HS. In vitro prostaglandins (PGs) production by monocytes of asthmatics and normal subjects. J Allergy Clin Immunol 1981;suppl:10. (Abstract.)","journal-title":"J Allergy Clin Immunol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0091-6749(74)90081-5","article-title":"Aspirin intolerance. II. A prospective study in an atopic and normal population","volume":"53","author":"Settipane, G.A.; Chafee, F.H.; Klein, D.E.","year":"1974","unstructured":"Settipane GA, Chafee FH, Klein DE. Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Imnmunol 1974;53:200-4.","journal-title":"J Allergy Clin Imnmunol"},{"key":"ref_12","first-page":"\"S\" # \"133","article-title":"Desensitisation to acetylsalicylic acid (ASA) in ASA-sensitive patients with rhinosinusitis\/asthma. In: PAR: pseudo-allergic reactions","volume":"3","author":"Stevenson, D.D.; Pleskow, W.W.; Curd, J.G.; Simon, R.A.; Mathison, D.A.","year":"1982","unstructured":"Stevenson DD, Pleskow WW, Curd JG, Simon RA, Mathison DA. Desensitisation to acetylsalicylic acid (ASA) in ASA-sensitive patients with rhinosinusitis\/asthma. In: PAR: pseudo-allergic reactions. Vol 3. Basle: S Karger, 1982:133-56.","journal-title":"Vol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","article-title":"Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period","volume":"69","author":"Pleskow, W.W.; Stevenson, D.D.; Mathison, D.A.; Simon, R.A.; Schatz, M.; Zeiger, R.S.","year":"1982","unstructured":"Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982;69:11-9.","journal-title":"J Allergy Clin Immunol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0091-6749(83)90439-6","article-title":"Aspirin-sensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin","volume":"71","author":"Pleskow, W.W.; Stevenson, D.D.; Mathison, D.A.; Simon, R.A.; Schatz, M.; Zeiger, R.S.","year":"1983","unstructured":"Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin-sensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983;71:574-9.","journal-title":"J Allergy Clin Immunol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.7326\/0003-4819-88-4-508","article-title":"Asthma improved by nonsteroidal anti-inflammatory drugs","volume":"88","author":"Kordansky, D.; Adkinson, N.F.; Norman, P.S.; Rosenthal, R.R.","year":"1978","unstructured":"Kordansky D, Adkinson NF, Norman PS, Rosenthal RR. Asthma improved by nonsteroidal anti-inflammatory drugs. Ann Intern Med 1978;88:508-11.","journal-title":"Ann Intern Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0007-0971(83)90021-9","article-title":"Asthma improved by aspirin-like drugs. Br3'","volume":"77","author":"Szceklik, A.; Nizankowska, E.","year":"1983","unstructured":"Szceklik A, Nizankowska E. Asthma improved by aspirin-like drugs. Br3' Dis Chest 1983;77:153-85.","journal-title":"Dis Chest"},{"key":"ref_17","article-title":"Accepted","year":"1984","unstructured":"(Accepted 13 January 1984)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.288.6419.745","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.288.6419.745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T20:09:43Z","timestamp":1765397383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.288.6419.745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,3,10]]},"references-count":17,"journal-issue":{"issue":"6419","published-online":{"date-parts":[[1984,3,10]]},"published-print":{"date-parts":[[1984,3,10]]}},"alternative-id":["10.1136\/bmj.288.6419.745"],"URL":"https:\/\/doi.org\/10.1136\/bmj.288.6419.745","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"value":"0007-1447","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,3,10]]}}}